-
srdr.ahrq.gov/projects/1705/studies/197214
January 01, 2019 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
-
srdr.ahrq.gov/projects/1596/studies/192220
January 01, 2013 - Reset
Cancel
Study Preview
Study Title and Description
Indicated … Comments ( 0 ) |
Post/View
Title Data
Title
Indicated
-
srdr.ahrq.gov/projects/1705/studies/197220
January 01, 2000 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
-
srdr.ahrq.gov/projects/1705/studies/197183
January 01, 2007 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
-
srdr.ahrq.gov/projects/1705/studies/197192
January 01, 1998 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
-
srdr.ahrq.gov/projects/1705/studies/197194
January 01, 2006 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
-
srdr.ahrq.gov/projects/1705/studies/197201
January 01, 1999 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
-
srdr.ahrq.gov/projects/1705/studies/197206
infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
-
srdr.ahrq.gov/projects/1705/studies/197182
January 01, 2005 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
-
srdr.ahrq.gov/projects/1705/studies/197185
January 01, 2006 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
-
srdr.ahrq.gov/projects/1705/studies/197208
January 01, 2007 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
-
srdr.ahrq.gov/projects/1705/studies/197195
January 01, 2002 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
-
srdr.ahrq.gov/projects/1705/studies/197211
January 01, 1994 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
-
srdr.ahrq.gov/projects/1705/studies/197215
January 01, 2014 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
-
srdr.ahrq.gov/projects/1705/studies/197217
January 01, 2004 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
-
srdr.ahrq.gov/projects/1705/studies/197219
January 01, 2000 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
-
srdr.ahrq.gov/projects/1705/studies/197221
January 01, 2009 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
-
srdr.ahrq.gov/projects/1705/studies/197193
January 01, 1997 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
-
srdr.ahrq.gov/projects/1705/studies/197207
infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated
-
srdr.ahrq.gov/projects/1705/studies/197197
January 01, 2005 - infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated … acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated